Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Technology sector as a whole closed the day up 0.5% versus the S&P 500, which was up 0.3%. Laggards within the Technology sector included

BluePhoenix Solutions

(

BPHX

), down 2.0%,

Kingtone Wirelessinfo Solution

(

KONE

), down 3.3%,

CollabRx

(

CLRX

), down 5.0%,

TigerLogic

(

TIGR

), down 10.7% and

Tel Instrument Electronics

(

TIK

), down 3.9%.

TheStreet Ratings Group would like to highlight 3 stocks that pushed the sector lower today:

China Unicom (Hong Kong

(

CHU

) is one of the companies that pushed the Technology sector lower today. China Unicom (Hong Kong was down $0.26 (1.8%) to $14.47 on average volume. Throughout the day, 522,871 shares of China Unicom (Hong Kong exchanged hands as compared to its average daily volume of 408,400 shares. The stock ranged in price between $14.39-$14.56 after having opened the day at $14.44 as compared to the previous trading day's close of $14.73.

China Unicom (Hong Kong) Limited, an investment holding company, provides cellular and fixed-line voice, broadband and other Internet-related, information communications technology, and business and data communications services in China. China Unicom (Hong Kong has a market cap of $35.1 billion and is part of the telecommunications industry. Shares are down 2.2% year-to-date as of the close of trading on Friday. Currently there is 1 analyst who rates China Unicom (Hong Kong a buy, no analysts rate it a sell, and 2 rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates

China Unicom (Hong Kong

as a

hold

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year.

Highlights from TheStreet Ratings analysis on CHU go as follows:

  • CHINA UNICOM (HONG KONG) LTD has improved earnings per share by 30.0% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. This trend suggests that the performance of the business is improving. During the past fiscal year, CHINA UNICOM (HONG KONG) LTD increased its bottom line by earning $0.71 versus $0.47 in the prior year. This year, the market expects an improvement in earnings ($0.86 versus $0.71).
  • The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Diversified Telecommunication Services industry average. The net income increased by 28.0% when compared to the same quarter one year prior, rising from $501.97 million to $642.67 million.
  • 36.85% is the gross profit margin for CHINA UNICOM (HONG KONG) LTD which we consider to be strong. It has increased from the same quarter the previous year. Regardless of the strong results of the gross profit margin, the net profit margin of 5.85% trails the industry average.
  • The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. In comparison to the other companies in the Diversified Telecommunication Services industry and the overall market, CHINA UNICOM (HONG KONG) LTD's return on equity is significantly below that of the industry average and is below that of the S&P 500.
  • In its most recent trading session, CHU has closed at a price level that was not very different from its closing price of one year earlier. This is probably due to its weak earnings growth as well as other mixed factors. Looking ahead, other than the push or pull of the broad market, we do not see anything in the company's numbers that may help reverse the decline experienced over the past 12 months. Despite the past decline, the stock is still selling for more than most others in its industry.

You can view the full analysis from the report here:

China Unicom (Hong Kong Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close,

CollabRx

(

CLRX

) was down $0.03 (5.0%) to $0.57 on average volume. Throughout the day, 17,130 shares of CollabRx exchanged hands as compared to its average daily volume of 15,100 shares. The stock ranged in price between $0.57-$0.65 after having opened the day at $0.62 as compared to the previous trading day's close of $0.60.

CollabRx, Inc. provides cloud-based expert systems to inform healthcare decision-making. The company's cloud-based expert systems provide clinical knowledge to institutions, physicians, researchers, and patients for genomics-based medicine in cancer. CollabRx has a market cap of $1.8 million and is part of the telecommunications industry. Shares are down 84.2% year-to-date as of the close of trading on Friday. Currently there is 1 analyst who rates CollabRx a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates

CollabRx

as a

sell

. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.

Highlights from TheStreet Ratings analysis on CLRX go as follows:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Technology industry. The net income has significantly decreased by 56.6% when compared to the same quarter one year ago, falling from -$0.80 million to -$1.25 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Technology industry and the overall market, COLLABRX INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has decreased to -$0.73 million or 19.96% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 85.69%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 74.28% compared to the year-earlier quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • COLLABRX INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. We feel it is likely to report a decline in earnings in the coming year. During the past fiscal year, COLLABRX INC continued to lose money by earning -$1.78 versus -$2.15 in the prior year. For the next year, the market is expecting a contraction of 3.9% in earnings (-$1.85 versus -$1.78).

You can view the full analysis from the report here:

CollabRx Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

BluePhoenix Solutions

(

BPHX

) was another company that pushed the Technology sector lower today. BluePhoenix Solutions was down $0.07 (2.0%) to $3.49 on average volume. Throughout the day, 1,549 shares of BluePhoenix Solutions exchanged hands as compared to its average daily volume of 1,700 shares. The stock ranged in price between $3.49-$3.68 after having opened the day at $3.50 as compared to the previous trading day's close of $3.56.

BluePhoenix Solutions Ltd. develops and markets enterprise legacy lifecycle information technology (IT) modernization solutions worldwide. BluePhoenix Solutions has a market cap of $40.6 million and is part of the telecommunications industry. Shares are down 23.3% year-to-date as of the close of trading on Friday.

TheStreet Ratings rates

BluePhoenix Solutions

as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Highlights from TheStreet Ratings analysis on BPHX go as follows:

  • The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. Compared to other companies in the Software industry and the overall market, BLUEPHOENIX SOLUTIONS LTD's return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has significantly decreased to -$0.48 million or 127.35% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • BPHX has underperformed the S&P 500 Index, declining 15.96% from its price level of one year ago. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.
  • The revenue fell significantly faster than the industry average of 28.4%. Since the same quarter one year prior, revenues fell by 20.4%. Weakness in the company's revenue seems to not be hurting the bottom line, shown by stable earnings per share.
  • 46.15% is the gross profit margin for BLUEPHOENIX SOLUTIONS LTD which we consider to be strong. Despite the high profit margin, it has decreased significantly from the same period last year. Despite the mixed results of the gross profit margin, BPHX's net profit margin of -39.97% significantly underperformed when compared to the industry average.

You can view the full analysis from the report here:

BluePhoenix Solutions Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.